TLX having yet another go at that 4.70/4.80 resistance zone.
MSB continuing to benefit from that highly controversial FDA Alzheimer drug approval earlier in the week. Possibly with the thought that if the FDA approved that, it gives MSB a better chance of getting approvals in the future. Now at $2.14 after having spent a lot of time under $2 recently.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 07 June
Short Term Trading Week Starting: 07 June, page-97
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)